Table 2.
Distribution of inappropriate colonoscopies according to EPAGE and EPAGE-II criteria by indications
Inappropriate indications | EPAGE I n (%) |
95% CI | EPAGE II n (%) |
95% CI |
---|---|---|---|---|
Iron deficiency anemia | 4 (2.3) | 0.07–4.57 | 1 (0.7) | 0.0001–2.08 |
Hematochezia | 35 (20.3) | 14.33–26.36 | 2 (1.4) | 0.0001–3.34 |
Lower abdominal pain | 28 (16.2) | 10.76–21.79 | 60 (42.2) | 34.12–50.37 |
Change in bowel habits | 1 (0.5) | 0.0001–1.71 | 2 (1.4) | 0.0001–3.34 |
Uncomplicated Diarrhea | 23 (13.3) | 8.28–18.45 | 2 (1.4) | 0.0001–3.34 |
Evaluation of known Ulcerative colitis | 22 (12.7) | 7.79–17.78 | 20 (14.0) | 8.36–19.80 |
Evaluation of known Crohn’s disease | 14 (8.1) | 4.05–12.22 | 12 (8.4) | 3.87–13.02 |
Surveillance post polypectomy | 34 (19.7) | 13.81–25.71 | 39 (27.4) | 20.12–34.80 |
Surveillance after curative intent resection of CRC | 2 (1.1) | 0.0001–2.76 | 1 (0.7) | 0.0001–2.08 |
CRC screening | 1 (0.5) | 0.0001–1.71 | 1 (0.7) | 0.0001–2.08 |
Other | 8 (4.5) | 1.50–7.79 | 2 (1.4) | 0.0001–3.34 |
Total | 172 (100) | 142 (100) |